COG - Fall Group Meeting 2026 (for Pharmacists)

Tuesday, October 6, 2026, 8:00 AM - Friday, October 9, 2026, 4:00 PM, Chicago, Illinois

Pharmacists are eligible for up to 2 hours of continuing pharmacy education (CPE) credit for the sessions listed below.  Additional information, for example dates and times, will be provided when available.

Deciphering a New Treatment Paradigm in Neuroblastoma

Practical Considerations for Children's Oncology Group Clinical Trials

To register for this conference, click here.

To be eligible to claim pharmacy CE credits, participants must:

• Register for the COG Fall Group Meeting

• Create a CloudCME account (cme.stjude.org)

• Update Profile

  • Login > MyCME > Profile

  • Profiles MUST contain NABP# and month/day of date of birth for CE credit to be awarded

• Text Attendance within 24 hours of the CE presentation

  • Attendance code will be provided during the presentation

  • Click here for instructions on how to text attendance

• Complete the post-test and evaluation in CloudCME by 10/30/26 (at 11:59 CST)

  • Login > MyCME > Tests 

  • Login > MyCME > Evaluations and Certificates

St. Jude Children's Research Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

St. Jude Children’s Research Hospital designates this for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The faculty for this activity are listed below. Click to view the faculty member's financial disclosure information and bio. 

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.